PMC:7102662 / 16956-17167 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T152","span":{"begin":142,"end":150},"obj":"Disease"},{"id":"T153","span":{"begin":168,"end":210},"obj":"Disease"},{"id":"T154","span":{"begin":189,"end":210},"obj":"Disease"}],"attributes":[{"id":"A152","pred":"mondo_id","subj":"T152","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A153","pred":"mondo_id","subj":"T153","obj":"http://purl.obolibrary.org/obo/MONDO_0041656"},{"id":"A154","pred":"mondo_id","subj":"T154","obj":"http://purl.obolibrary.org/obo/MONDO_0005068"}],"text":"The individual hospitals may also have to reconsider risk-benefit ratio of primary percutaneous intervention vs fibrinolysis in patients with COVID-19 who present with ST-segment elevation myocardial infarction."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T102","span":{"begin":168,"end":170},"obj":"http://purl.obolibrary.org/obo/CLO_0009141"},{"id":"T103","span":{"begin":168,"end":170},"obj":"http://purl.obolibrary.org/obo/CLO_0050980"}],"text":"The individual hospitals may also have to reconsider risk-benefit ratio of primary percutaneous intervention vs fibrinolysis in patients with COVID-19 who present with ST-segment elevation myocardial infarction."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T23","span":{"begin":168,"end":170},"obj":"Chemical"}],"attributes":[{"id":"A23","pred":"chebi_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/CHEBI_141393"}],"text":"The individual hospitals may also have to reconsider risk-benefit ratio of primary percutaneous intervention vs fibrinolysis in patients with COVID-19 who present with ST-segment elevation myocardial infarction."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T45","span":{"begin":168,"end":188},"obj":"Phenotype"},{"id":"T46","span":{"begin":189,"end":210},"obj":"Phenotype"}],"attributes":[{"id":"A45","pred":"hp_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/HP_0012251"},{"id":"A46","pred":"hp_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/HP_0001658"}],"text":"The individual hospitals may also have to reconsider risk-benefit ratio of primary percutaneous intervention vs fibrinolysis in patients with COVID-19 who present with ST-segment elevation myocardial infarction."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T22","span":{"begin":112,"end":124},"obj":"http://purl.obolibrary.org/obo/GO_0042730"}],"text":"The individual hospitals may also have to reconsider risk-benefit ratio of primary percutaneous intervention vs fibrinolysis in patients with COVID-19 who present with ST-segment elevation myocardial infarction."}

{"project":"LitCovid-sentences","denotations":[{"id":"T140","span":{"begin":0,"end":211},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The individual hospitals may also have to reconsider risk-benefit ratio of primary percutaneous intervention vs fibrinolysis in patients with COVID-19 who present with ST-segment elevation myocardial infarction."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T271","span":{"begin":112,"end":124},"obj":"GO:0042730"},{"id":"T272","span":{"begin":142,"end":150},"obj":"SP_7"},{"id":"T273","span":{"begin":189,"end":199},"obj":"UBERON:0002349"},{"id":"T86273","span":{"begin":164,"end":168},"obj":"GO:0016265"},{"id":"T62094","span":{"begin":176,"end":180},"obj":"SP_10"},{"id":"T86471","span":{"begin":200,"end":204},"obj":"SP_10"},{"id":"T313","span":{"begin":112,"end":124},"obj":"GO:0042730"},{"id":"T314","span":{"begin":142,"end":150},"obj":"SP_7"},{"id":"T315","span":{"begin":189,"end":199},"obj":"UBERON:0002349"}],"text":"The individual hospitals may also have to reconsider risk-benefit ratio of primary percutaneous intervention vs fibrinolysis in patients with COVID-19 who present with ST-segment elevation myocardial infarction."}

{"project":"LitCovid-PubTator","denotations":[{"id":"485","span":{"begin":128,"end":136},"obj":"Species"},{"id":"486","span":{"begin":142,"end":150},"obj":"Disease"},{"id":"487","span":{"begin":189,"end":210},"obj":"Disease"}],"attributes":[{"id":"A485","pred":"tao:has_database_id","subj":"485","obj":"Tax:9606"},{"id":"A486","pred":"tao:has_database_id","subj":"486","obj":"MESH:C000657245"},{"id":"A487","pred":"tao:has_database_id","subj":"487","obj":"MESH:D009203"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The individual hospitals may also have to reconsider risk-benefit ratio of primary percutaneous intervention vs fibrinolysis in patients with COVID-19 who present with ST-segment elevation myocardial infarction."}